Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
AUTOR(ES)
Godwin-Austen, R B
RESUMO
The effects of bromocriptine and levodopa were compared in a blind trial in 18 patients with Parkinson's disease. Optimal doses of the two drugs were given in identical capsules: there was no significant difference between the therapeutic effects. There were wide individual differences in response to the two drugs. Side effects were more common with bromocriptine because of side effects.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492723Documentos Relacionados
- Bromocriptine treatment in Parkinson's disease.
- Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease.
- Comparison of motor response to apomorphine and levodopa in Parkinson's disease.
- Bromocriptine induced impotence in Parkinson's disease.
- Low-dose bromocriptine in Parkinson's disease.
